Dr. Jinoos Yazdanya, a rheumatologist from the University of California, San Francisco, and NPR science correspondent Joe Palca answer questions about the drug hydroxychloroquine.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Trump again touts unproven drug to treat coronavirus: ‘What do you have to lose?’President Donald Trump on Sunday again strongly backed hydroxychloroquine to treat patients with COVID-19, despite scant scientific evidence that it’s an...
Lire la suite »
Opinion: Looks like Rudy Giuliani is now advising Trump on COVID-19 and hydroxychloroquine. YikesAccording to the Washington Post, Giuliani has been lobbying Trump in favor of treating COVID-19 with hydroxychloroquine.
Lire la suite »
Most people recover from Covid-19. Here's why it's hard to pinpoint exactly how manyNot much research has been done into people who recover from coronavirus. Here's why it's important
Lire la suite »
Apple in the age of COVID-19: Can new iPhones be made, and who will buy them?For Apple Inc., the most valuable U.S. company, COVID-19 creates questions about supply and demand.
Lire la suite »
Fact check: Trump doubles down on unproven hydroxychloroquine claimsThe president spent much of his Sunday night briefing boasting about the unproven, potential use of the antimalarial drug as a COVID-19 treatment.
Lire la suite »
Hydroxychloroquine and Covid-19: an explainerThere have been indications that hydroxychloroquine, an anti-malarial and anti-rheumatic drug, could be effective in treating Covid-19 -- but studies have come to conflicting conclusions. Here's what we know:
Lire la suite »